Embracing industrial symbiosis goes beyond ethical responsibility; it’s a chance for companies to lower costs, reduce ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Barclays analysts are bullish on Novo Nordisk (NYSE:NVO) stock ahead of the December release of pivotal clinical trial data ...

Ingen grund til at satse butikken, når usikkerheden trænger sig på. Investorer holder på pengene før skæbnedata fra Novo Novo Nordisk har været i investormodvind over det seneste kvartal, da skuffende ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Bagsværd, Denmark, 8 November 2024 - Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 4,736,088,225.00 from Novo Holdings A/S. The ...

The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, ...

SINGAPORE - Media OutReach Newswire - 22 December 2023 - Novo Nordisk Pharma (Thailand) Ltd. has emerged triumphant by securing three prestigious accolades at the Asia Pacific Enterprise Awards (APEA) ...

even their letter O sometimes comes slashed in half. But, Denmark is also home to what is suddenly Europe's largest company—Novo Nordisk…. a pharmaceutical firm with a market cap of a half ...

(RTTNews) - Novo Nordisk (NVO) reported net profit for the first nine months of 2024 of 72.76 billion Danish Kroner up from 61.72 billion Kroner in the prior year. On a per share basis, net income ...

NYT AFSNIT 'I HOVEDET PÅ PETER LUNDIN' NYT AFSNIT 'I HOVEDET PÅ PETER LUNDIN' NYT AFSNIT 'I HOVEDET PÅ PETER LUNDIN' NYT AFSNIT 'I HOVEDET PÅ PETER LUNDIN' NYT ...